down arrow

Chemo Pharma Lab

  • Market Cap: Micro Cap
  • Industry: Miscellaneous
  • ISIN: INE320M01019
  • NSEID:
  • BSEID: 506365
INR
124.45
2.4 (1.97%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 14.72 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

119.65124.45

52 Week

55.10154.00
Valuation
Technical
Day's Volume

CASH

14.72 k (997.50%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.37%

Held by 0 DIIs

Promoter

27.89%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

INR 19 Cr (Micro Cap)

stock-summary
P/E

18.00

stock-summary
Industry P/E

28

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.49

stock-summary
Return on Equity

2.93%

stock-summary
Price to Book

1.34

Revenue and Profits (1 Year):
Net Sales:
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
60.64%
0%
60.64%
1 Year
55.64%
0%
55.64%
2 Years
199.88%
0%
199.88%
3 Years
226.21%
0%
226.21%
4 Years
563.73%
0%
563.73%
5 Years
1974.17%
0%
1974.17%

Chemo Pharma Lab for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
4.40%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.37%
ROCE (avg)
-8.90%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
18
Industry P/E
28
Price to Book Value
1.34
EV to EBIT
-11.56
EV to EBITDA
-11.56
EV to Capital Employed
1.67
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-3.04%
ROE (Latest)
2.93%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Citric India Ltd (24.63%)

Highest Public shareholder

Shree Consultation And Services Pvt Ltd (3.63%)

Individual Investors Holdings

65.5%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -125.00% vs 325.00% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.03",
          "val2": "-0.03",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.17",
          "val2": "0.68",
          "chgp": "-125.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 0.00% vs 0.00% in Sep 2023",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 4.88% vs 2,633.33% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.08",
          "val2": "-0.07",
          "chgp": "-14.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.86",
          "val2": "0.82",
          "chgp": "4.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -54.00% vs 689.47% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.11",
          "val2": "-0.10",
          "chgp": "-10.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.69",
          "val2": "1.50",
          "chgp": "-54.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 0.00% vs 0.00% in Mar 2023",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 2,300.00% vs -91.07% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.18",
          "val2": "-0.21",
          "chgp": "14.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.20",
          "val2": "0.05",
          "chgp": "2,300.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.03
-0.03
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.17
0.68
-125.00%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is -125.00% vs 325.00% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.08
-0.07
-14.29%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.86
0.82
4.88%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
stock-summary Compare with Peers
Net Sales

Growth in half year ended Sep 2024 is 0.00% vs 0.00% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 4.88% vs 2,633.33% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.11
-0.10
-10.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.69
1.50
-54.00%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
stock-summary Compare with Peers
Net Sales

YoY Growth in nine months ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is -54.00% vs 689.47% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.18
-0.21
14.29%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
1.20
0.05
2,300.00%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Mar 2024 is 0.00% vs 0.00% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 2,300.00% vs -91.07% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Chemo Pharma Laboratories Ltd stock-summary
stock-summary
Chemo Pharma Laboratories Ltd
Micro Cap
Miscellaneous
Chemo Pharma Laboratories Limited was established in August, 1942 and has been making Pharmaceuticals and also had diversified into bulk drugs. However due to increase in competition and flow of new drugs, the Company had to dispose the business and pay all its liabilities and dues. Presently the Company has its own cash resource, with this the Company is proposing to diversify and to take over Sick Company which has excellent future potential.
Company Coordinates stock-summary
Company Details
5 Kumud Apartment CHS Ltd, Karnik Road Chikan Ghar Kalyan Thane Maharashtra : 421301
stock-summary
Tel: 91-022-22078381/22078382
stock-summary
http://www.thechemopharmalaboratoriesltd.com
stock-summary
chemopharmalab@gmail.com
Registrar Details
Purva Shareregistry (India) Pvt Ltd , Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E], Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."